Edition:
United Kingdom

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

1.92USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,366
52-wk High
$7.75
52-wk Low
$1.64

Chart for

About

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $7.39
Shares Outstanding(Mil.): 3.34
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Bioblast Pharma reports Q3 loss per share $0.32

* Bioblast Pharma reports third quarter 2017 financial results

02 Nov 2017

BRIEF-Bioblast announces effectiveness of five to one reverse split

* Bioblast announces effectiveness of five to one reverse split

25 Sep 2017

BRIEF-Bioblast Pharma reports Q2 loss per share $0.10

* Bioblast Pharma reports second quarter 2017 financial results

04 Aug 2017

Earnings vs. Estimates